These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33541681)

  • 1. Role of central serotonin and noradrenaline interactions in the antidepressants' action: Electrophysiological and neurochemical evidence.
    Delcourte S; Etievant A; Haddjeri N
    Prog Brain Res; 2021; 259():7-81. PubMed ID: 33541681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.
    Artigas F; Bortolozzi A; Celada P
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):445-456. PubMed ID: 29174531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.
    El Mansari M; Guiard BP; Chernoloz O; Ghanbari R; Katz N; Blier P
    CNS Neurosci Ther; 2010 Jun; 16(3):e1-17. PubMed ID: 20406250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?
    Pringle A; McCabe C; Cowen PJ; Harmer CJ
    J Psychopharmacol; 2013 Aug; 27(8):719-31. PubMed ID: 23392757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine.
    López-Gil X; Jiménez-Sánchez L; Campa L; Castro E; Frago C; Adell A
    ACS Chem Neurosci; 2019 Jul; 10(7):3318-3326. PubMed ID: 31244055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants and serotonin neurons of the raphe.
    Constantinidis J; Dick P; Tissot R
    Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in the field of antidepressants, where do we go now?
    Artigas F
    Eur Neuropsychopharmacol; 2015 May; 25(5):657-70. PubMed ID: 23706576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus.
    Yoshitake T; Reenilä I; Ogren SO; Hökfelt T; Kehr J
    Neurosci Lett; 2003 Mar; 339(3):239-42. PubMed ID: 12633897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence.
    Mendiguren A; Aostri E; Pineda J
    Adv Exp Med Biol; 2021; 1297():111-132. PubMed ID: 33537940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
    Bortolozzi A; Celada P; Artigas F
    Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.
    Szabo ST; Blier P
    Eur J Neurosci; 2001 Jun; 13(11):2077-87. PubMed ID: 11422448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical aspects of depression: the past and the future?
    Jesberger JA; Richardson JS
    Int J Neurosci; 1985 Jul; 27(1-2):19-47. PubMed ID: 2991156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic Mechanisms of Antidepressants for Neuropathic Pain.
    Obata H
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.
    Hébert C; Habimana A; Elie R; Reader TA
    Neurochem Int; 2001 Jan; 38(1):63-74. PubMed ID: 10913689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of putative early-onset antidepressant strategies.
    Blier P
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):57-66. PubMed ID: 12650947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological basis of depression and therapeutic relevance.
    Richelson E
    J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.